MedPath

Local Anesthetic Nebulization for Pain Control After Laparoscopic Cholecystectomy

Phase 3
Completed
Conditions
Laparoscopic Cholecystectomy
Interventions
Registration Number
NCT01247857
Lead Sponsor
San Gerardo Hospital
Brief Summary

Intraperitoneal nebulization of local anesthetic is a novel approach to pain management after laparoscopy. Preoperative compared with postoperative administration of analgesia remains controversial. This randomized, double blind, placebo-controlled trial compared the analgesic efficacy of preoperative with postoperative peritoneal ropivacaine nebulization in patients undergoing elective laparoscopic cholecystectomy.

Detailed Description

Previous studies evaluating intraperitoneal local anesthetic administration for pain relief after laparoscopic surgery have suggested that the timing of local anesthetic administration may be critical in the success of the technique. A meta-analysis of randomized trials of intraperitoneal local anesthetic instillation in patients undergoing laparoscopic surgery found that local anesthetic instilled before surgical dissection provided superior pain relief compared to instillation at the end of surgery. Intraperitoneal nebulization of local anesthetic is a novel approach to pain management after laparoscopic surgery. Recently, Alkhamesi et al reported that bupivacaine nebulization performed at the end of laparoscopic cholecystectomy significantly reduced postoperative pain. However, clinical benefits of preoperative administration of analgesia, compared with postoperative administration, remains controversial.

The investigators hypothesized that pain relief after preoperative and postoperative ropivacaine nebulization would be similar but better than placebo.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • ASA Score I-III
  • Scheduled for laparoscopic cholecystectomy
  • Free from pain in preoperative period
  • Not using analgesic drugs before surgery
  • Without cognitive impairment or mental retardation
  • Written informed consent
Exclusion Criteria
  • Emergency/urgency surgery
  • Postoperative admission in an intensive care unit
  • Cognitive impairment or mental retardation
  • Progressive degenerative diseases of the CNS
  • Seizures or chronic therapy with antiepileptic drugs
  • Severe hepatic or renal impairment
  • Pregnancy or lactation
  • Allergy to one of the specific drugs under study
  • Acute infection or inflammatory chronic disease
  • Alcohol or drug addiction

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Preoperative NebulizationRopivacaine 30 mgNebulization of 30 mg of Ropivacaine in the peritoneal cavity before surgery
Postoperative NebulizationRopivacaine 30 mgNebulization of 30 mg of Ropivacaine in the peritoneal cavity after surgery
ControlSalineNebulization of normal saline 3 ml before and after surgery
Primary Outcome Measures
NameTimeMethod
Postoperative Pain48 hours

Postoperative pain will be assessed by numeric ranking scale (NRS 0 to 10 points) at rest (static NRS) and after a deep inspiration or cough (dynamic NRS). The proportion of patients with adequate pain control after surgery (dynamic NRS \< 3) will also be assessed.

Secondary Outcome Measures
NameTimeMethod
Time of unassisted walkingUp to 48 hours

Unassisted walking time is defined as the time in hours between PACU discharge and when the patient is able to walk out of his room and back to bed without any assistance.

Morphine consumption (mg)Up to 48 hours

The total dose of morphine at every evaluation after awakening will be quantified using the PACU clinical chart and/or PCA infusers memory display

Hospital morbidityUp to 48 hours

All complications or adverse effects associated or possibly associated with the interventions under study, surgery or anesthesia will be quantified using the anesthesia charts, surgical charts, surgical database.

Time to hospital discharge48 hours

We define hospital stay as the elapsed time between surgery and hospital discharge

Trial Locations

Locations (1)

San Gerardo Hospital

🇮🇹

Monza, MB, Italy

© Copyright 2025. All Rights Reserved by MedPath